PG&E to Sell San Francisco Headquarters, Move to Oakland

PG&E to Sell San Francisco Headquarters, Move to Oakland

(Bloomberg) -- PG&E Corp. said it plans to sell its iconic downtown San Francisco headquarters and relocate to Oakland, a move aimed at lowering costs after the California power giant exits bankruptcy.PG&E, which has called San Francisco its home since the utility’s founding in 1905, will move in phases starting in 2022, the company said in a statement Monday. It plans to lease its new building at 300 Lakeside in Oakland, with the option to purchase the property from developer TMG Partners.With the move, PG&E becomes one of the most high-profile companies to leave San Francisco for Oakland, a cheaper city located just across San Francisco Bay. The sale of its headquarters also allows the utility to profit off of investor interest in its longtime hometown, one of the tightest and most expensive U.S. office markets.PG&E said any net gains realized from a sale would be passed on to customers, and...

Cathay, Swire Pacific, Air China Suspend Trading in Hong Kong

(Bloomberg) -- Embattled Hong Kong carrier Cathay Pacific Airways Ltd. and its two main shareholders, Swire Pacific Ltd. and Air China Ltd., suspended trading of their shares Tuesday pending an announcement.The move comes as Cathay contends with a slump in traffic brought on by the coronavirus outbreak and the travel restrictions that ensued. The curbs hit Cathay particularly hard because it has no domestic market to fall back on, whereas carriers in China are rebuilding capacity on flights within the mainland.Even before the pandemic, Cathay was under enormous financial and political pressures as it found itself caught up in the Hong Kong anti-government protests, which affected traffic numbers and led to the exit of the company’s former chief executive officer. Cathay was criticized by China, protesters and its own workers for its response to the demonstrations.Air China has owned about 30% of Cathay for more than a decade, while Swire, one...

A $26 Billion Truck Company With Zero Revenue Just Surged 103%

(Bloomberg) -- Tesla Inc. shares are at an all-time high. Hertz Global Holdings Inc.’s are well above where they were before the company went bankrupt. But no stock in the automotive sector is a better indication of equity-market exuberance than Nikola Corp.The aspiring battery-electric and hydrogen fuel-cell truck maker debuted on the Nasdaq last week following a reverse merger with a blank-check company headed by a former General Motors Co. executive and board director. It’s forecasting zero revenue for 2020 and its first $1 billion year won’t be until 2023.Ford Motor Co., by comparison, is expected to report about $115 billion of revenue for this year. And yet Nikola, whose stock more than doubled Monday, traded up another 30% to as high as $95 after the close, giving the company a richer market capitalization than the almost 117-year-old maker of the F-150.Skeptics have long questioned the market’s valuation of Tesla, which...

Cathay Pacific, major shareholders Swire and Air China halt trading in Hong Kong

Cathay Pacific Airways Ltd and its major shareholders Swire Pacific Ltd and Air China Ltd halted trading in their shares in Hong Kong on Tuesday pending announcements. Cathay's management team on Friday met with the leaders of pilot unions at Cathay Pacific and its regional arm Cathay Dragon to brief them on condition of confidentiality ahead of an announcement expected on Tuesday, three sources with knowledge of the matter told Reuters. A fourth person said Hong Kong's Cathay was poised to announce a new chief executive at Dragon along with some other senior management changes....

After Novavax Inks DoD Contract, Is Operation Warp Speed Ahead? Top Analyst Weighs In

Another day, another stride forward in the race to develop a COVID-19 vaccine.On June 4, Novavax (NVAX) revealed it will receive $60 million from the U.S. Department of Defense (DoD) to further the advancement of its experimental vaccine candidate, NVX-CoV2373, in the U.S., through JPEOCBRND-EB (Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies).As per the terms of the agreement, NVAX will work with multiple biologics contract development manufacturing organizations (CDMO) based in the U.S. to increase the scale of antigen and Matrix-M adjuvant production, which are both components of the vaccine. The end goal is to produce 10 million doses for the DoD in 2020, which will then be used in either a Phase 2/3 trial or under an Emergency Use Authorization (EUA).Weighing in on this development for B.Riley FBR, five-star analyst Mayank Mamtani tells investors he’s “encouraged” by the grant, arguing that the U.S. military...